etofenprox
Small moleculeexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Oct 1, 2020 (NCT05150808)
Timeline
2020s
- Jan 1, 2020
Earliest Phase 3 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Loading structure…
SMILES
CCOc1ccc(C(C)(C)COCc2cccc(Oc3ccccc3)c2)cc1- Mol. weight
- 376.5 g/mol
- Lipinski Ro5
- 1 violation(s)
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL2105573 ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05150808 | Phase 3 | Oct 1, 2020 | Kilimanjaro Christian Medical College, Tanzania, National Institute for Medical Research, Tanzania, University of London |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Kilimanjaro Christian Medical College, Tanzania | Academic/Hospital | 1 | 0 | 1 | 2020 |
| National Institute for Medical Research, Tanzania | Government | 1 | 0 | 1 | 2020 |
| University of London | Academic/Hospital | 1 | 1 | 1 | 2020 |
3 organizations
Page 1 / 1